Bicocca Open Archive

Logo unimib boa
SENNI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.259
EU - Europa 4.792
AS - Asia 3.387
SA - Sud America 131
AF - Africa 20
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.071
HK - Hong Kong 1.354
IE - Irlanda 1.329
SG - Singapore 1.267
RU - Federazione Russa 981
IT - Italia 902
DE - Germania 595
SE - Svezia 490
CN - Cina 413
CA - Canada 174
ID - Indonesia 141
BR - Brasile 112
GB - Regno Unito 102
UA - Ucraina 72
IN - India 71
FI - Finlandia 62
AT - Austria 57
BE - Belgio 42
NL - Olanda 38
VN - Vietnam 33
FR - Francia 24
IR - Iran 20
DK - Danimarca 18
JP - Giappone 16
TR - Turchia 12
MX - Messico 11
RO - Romania 11
CZ - Repubblica Ceca 10
NO - Norvegia 10
PL - Polonia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
ES - Italia 7
KR - Corea 7
NZ - Nuova Zelanda 7
EC - Ecuador 6
LV - Lettonia 6
PK - Pakistan 6
AR - Argentina 5
BD - Bangladesh 5
EG - Egitto 5
PH - Filippine 5
TN - Tunisia 5
CH - Svizzera 4
EU - Europa 4
MY - Malesia 4
PT - Portogallo 4
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
IQ - Iraq 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
CO - Colombia 2
LK - Sri Lanka 2
MK - Macedonia 2
PA - Panama 2
SC - Seychelles 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
NP - Nepal 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 15.609
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.350
Dublin 1.283
Singapore 1.007
Chandler 806
Princeton 744
Ann Arbor 578
New York 477
Frankfurt am Main 456
Ashburn 416
Santa Clara 324
Lawrence 291
Fairfield 288
Altamura 268
Toronto 152
Andover 147
Jakarta 140
Wilmington 129
Seattle 113
Milan 111
Cambridge 108
San Diego 104
Woodbridge 101
Houston 85
Nuremberg 84
Shanghai 73
Los Angeles 65
Boardman 57
Beijing 56
Helsinki 52
Pune 51
Rome 51
San Mateo 50
Washington 44
Brussels 39
London 29
Dong Ket 28
Vienna 28
Chicago 25
Guangzhou 25
Dearborn 22
Naples 19
Cedar Knolls 18
Dallas 18
Nanjing 18
Fremont 13
São Paulo 13
Laurel 12
Turin 12
Kilburn 11
Brescia 10
Lappeenranta 10
Aci Castello 8
Bergamo 8
Jinan 8
Prescot 8
Tianjin 8
Bologna 7
Changsha 7
Jacksonville 7
Norwalk 7
Alexandria 6
Amsterdam 6
Azzano San Paolo 6
Belo Horizonte 6
Copenhagen 6
Coventry 6
Guadalupe 6
Ivry-sur-Seine 6
Leawood 6
Montréal 6
Oslo 6
Padova 6
Palermo 6
Riga 6
Sacramento 6
San Francisco 6
San Giuliano Milanese 6
Tabriz 6
Winnipeg 6
Zanjan 6
Bari 5
Cagliari 5
Cesano Maderno 5
Esslingen am Neckar 5
Florence 5
Genzano Di Roma 5
Guayaquil 5
Handan 5
Manassas 5
Manila 5
Nanning 5
Newark 5
Prineville 5
Tappahannock 5
Wuhan 5
Zhengzhou 5
Auckland 4
Aversa 4
Brno 4
Brooklyn 4
Totale 10.695
Salva come PNG Salva come JPEG
Nome #
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 407
Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis multicenter Lombardy registry 261
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 217
Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study 186
Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study 172
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 169
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 167
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 148
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 146
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction 145
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysis 142
The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique 135
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure 135
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study 129
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 122
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 114
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 114
QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance 103
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 100
Position paper ANMCO sull'utilizzo della terapia con sacubitril/valsartan nel paziente con scompenso cardiaco [ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure] 96
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 90
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis 89
Heart failure with preserved ejection fraction: Update on diagnosis and therapy [Scompenso cardiaco con frazione di eiezione preservata: Update in tema di diagnosi e terapia] 89
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 87
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials [Position paper della Società Italiana di Cardiologia: Il blocco del sistema renina-angiotensina-aldosterone (RAAS) nel paziente con scompenso cardiaco – Parte I: Dalla scoperta del RAAS ai trial clinici] 86
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry 81
Erratum: Heart failure at the crossroads: Moving beyond blaming stakeholders to targeting the heart (Eur J Heart Fail (2015) 17:8 (760-763) doi:10.1002/ejhf.315)) 78
An unusual case of cardiac aspergillosis 75
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 74
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 74
Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives [Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici] 73
Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome 72
Evolocumab and clinical outcomes in patients with cardiovascular disease 72
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity 69
Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion [Grey zones sull'uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinioni degli esperti] 69
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 69
Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients 67
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 66
Tailored approach to trans-catheter palliation of critically reduced pulmonary blood supply. Data on long term follow up 65
Trattamento conservativo della valvola mitrale in presenza di endocardite infettiva 63
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 63
Vasopressors and inotropes in cardiogenic shock: Is there room for "adrenaline resuscitation"? 63
Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation 63
Ejection fraction of 20% or less is not a contraindication to cardiac surgery 63
Emergency surgery of acute coronary insufficiency [La chirurgia d'urgenza nell'insufficienza coronarica acuta.] 63
Assistenza ventricolare sinistra dopo correzione combinata di stenosi valvolare aortica e coartazione istmica 61
The follow-up of patients undergoing percutaneous coronary intervention: Potential impact of the application of a clinical pathway-structured management on the hospital-community integration and modulated on the patient's clinical risk 61
Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol 60
Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: The relevance of the left ventricular equator as a prognostic factor 59
Trapianto cardiaco in età pediatrica: esperienza in 34 casi 59
Postcardiotomy recovery after repair of congenital defects-comparison of extracorporeal membrane oxygenation with ventricular assist device 58
Pediatric heart transplantation without chronic maintenance steroids 58
Good survival of patients considered too-well for heart transplantation 58
Aspirin Desensitization in Patients with Coronary Artery Disease 57
Importanza dell’ecocardiografia transtoracica e transesofagea nell’assistenza cardiocircolatoria meccanica 56
Ruolo dell’ecocardiografia transesofagea nell’indicazione alla terapia chirurgica Delle endocarditi infettive 56
Prognosis of patients in waiting list for heart transplantation a multiparametric analysis 56
Screening of asymptomatic left ventricular diastolic dysfunction (ALVDD) in a high-risk population enrolled in a primary care setting through ECG and natriuretic peptides. The DAVID-BERG study 56
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 56
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF 56
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe 55
The PARAGON-HF trial: Missed opportunity or first personalized therapy? [Lo studio PARAGON-HF: Opportunità mancata o prima terapia personalizzata?] 55
Therapeutic options in end-stage heart failure. Journal of Molecular and Cellular 54
A 57-year-old man with rapidly progressive pulmonary hypertension 53
Hemodynamic arterial changes in heart failure: a proposed new paradigm of "Heart and Vessels Failure" 52
Effect of changes in flow on the determination of orifice area in the mitral position by pressure half-time 52
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 51
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial 51
Sex-related differences in patients with coronavirus disease 2019: Results of the Cardio-COVID-Italy multicentre study 51
Impact of chronic obstructive pulmonary disease in patients with heart failure with preserved ejection fraction: Insights from paragon-hf 50
Evaluation of the effects of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial 50
Prevention of left ventricular remodelling after acute myocardial infarction: an update 50
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs 50
Bacterial Pericarditis due to Providencia stuartii An Atypical Case of Relapsing Pericarditis 50
Chirurgia riparativa della mitrale in età pediatrica. Esperienza in 56 casi operati 49
Experience of a pediatric electrophysiology clinic during the COVID-19 pandemic 49
Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis 49
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 48
QRS fragmentation as a possible electrocardiographic diagnostic marker in patients with acute myocarditis: preliminary histopathological validation 48
Multivariate analysis of survival in patients in waiting list for heart transplantation 48
Can we improve the accuracy of electrocardiographic algorithms for accessory pathway location in children? 48
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial 48
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study 48
Heart rate and outcome in patients with acute and chronic heart failure [La frequenza cardiaca e la prognosi nello scompenso cardiaco acuto e cronico] 47
Microvascular ischaemia after cardiac arrest in a patient with hypertrophic cardiomyopathy 47
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak 47
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens 46
An innovative microemulsion galenic formulation of CyA: pharmacokinetics in long-term and “de novo” heart transplanted patients 46
Mechanical assisted circulation- comparison between two different anticoagulation protocols- preliminary results in 45 patients 46
Telemedicine and Teleconsulting in the Era of COVID-19 Pandemic: A Useful Tool from Screening to Intensive Care Monitoring 46
Angiotensin–neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure 46
Continuity of care in patients with cardiac failure after acute event [Percorsi e continuità assistenziale nel paziente con scompenso cardiaco dopo evento acuto] 46
S Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction 45
Feasibility and burden of multidimensional assessment of elderly heart failure patients in clinical practice: data from the image-HF registry 45
Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment 45
Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial 45
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 45
TAVI in moderate aortic stenosis and heart failure: pros and cons 45
Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence? 44
The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels 44
Totale 7.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 0 0 35 36 24 19 5
2020/2021757 35 58 93 36 41 49 73 54 66 68 81 103
2021/20222.953 79 76 77 45 88 27 28 49 41 63 1.676 704
2022/20233.988 640 1.090 282 272 208 769 54 195 273 42 95 68
2023/20243.637 68 105 98 138 590 1.004 689 92 333 95 38 387
2024/20255.475 466 1.221 441 471 1.283 473 1.104 16 0 0 0 0
Totale 17.162